AbbVie Inc. (VIE:ABBV)

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of EUR 353.50 billion. The enterprise value is 407.92 billion.

Market Cap	353.50B
Enterprise Value	407.92B

Important Dates

The last earnings date was Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	Oct 15, 2025

Share Statistics

Current Share Class	1.77B
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	72.28%
Float	1.76B

Valuation Ratios

The trailing PE ratio is 176.65 and the forward PE ratio is 16.98.

PE Ratio	176.65
Forward PE	16.98
PS Ratio	6.95
PB Ratio	-159.59
P/TBV Ratio	n/a
P/FCF Ratio	21.07
P/OCF Ratio	19.88
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.87, with an EV/FCF ratio of 24.32.

EV / Earnings	203.84
EV / Sales	7.95
EV / EBITDA	15.87
EV / EBIT	22.29
EV / FCF	24.32

Financial Position

The company has a current ratio of 0.72

Current Ratio	0.72
Quick Ratio	0.47
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.50
Interest Coverage	7.38

Financial Efficiency

Return on equity (ROE) is 137.96% and return on invested capital (ROIC) is 18.50%.

Return on Equity (ROE)	137.96%
Return on Assets (ROA)	9.59%
Return on Invested Capital (ROIC)	18.50%
Return on Capital Employed (ROCE)	22.50%
Revenue Per Employee	924,265
Profits Per Employee	36,385
Employee Count	55,000
Asset Turnover	0.43
Inventory Turnover	3.63

Taxes

Income Tax	-626.44M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.64% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+23.64%
50-Day Moving Average	192.60
200-Day Moving Average	178.28
Relative Strength Index (RSI)	56.18
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.36

Income Statement

In the last 12 months, AbbVie had revenue of EUR 50.83 billion and earned 2.00 billion in profits. Earnings per share was 1.13.

Revenue	50.83B
Gross Profit	36.33B
Operating Income	18.12B
Pretax Income	1.41B
Net Income	2.00B
EBITDA	25.16B
EBIT	18.12B
Earnings Per Share (EPS)	1.13

Balance Sheet

The company has 4.83 billion in cash and 58.68 billion in debt, giving a net cash position of -53.85 billion.

Cash & Cash Equivalents	4.83B
Total Debt	58.68B
Net Cash	-53.85B
Net Cash Per Share	n/a
Equity (Book Value)	-2.22B
Book Value Per Share	-1.27
Working Capital	-9.25B

Cash Flow

In the last 12 months, operating cash flow was 17.78 billion and capital expenditures -1.00 billion, giving a free cash flow of 16.78 billion.

Operating Cash Flow	17.78B
Capital Expenditures	-1.00B
Free Cash Flow	16.78B
FCF Per Share	n/a

Margins

Gross margin is 71.46%, with operating and profit margins of 35.65% and 4.00%.

Gross Margin	71.46%
Operating Margin	35.65%
Pretax Margin	2.78%
Profit Margin	4.00%
EBITDA Margin	49.49%
EBIT Margin	35.65%
FCF Margin	33.00%

Dividends & Yields

This stock pays an annual dividend of 5.86, which amounts to a dividend yield of 2.86%.

Dividend Per Share	5.86
Dividend Yield	2.86%
Dividend Growth (YoY)	2.64%
Years of Dividend Growth	8
Payout Ratio	481.49%
Buyback Yield	-0.01%
Shareholder Yield	2.84%
Earnings Yield	0.57%
FCF Yield	4.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.21 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.21
Piotroski F-Score	7